Texas Medical Board Approves Rules for Controversial Treatment

摘要

Last week, the Texas Medical Board signed off on what's said to be the first state-level policy imposing oversight on experimental treatments using adult stem cells. The scientific community has mixed views on whether this is a good way to raise standards. Some experts say the rule will allow unscrupulous doctors to avoid U.S. Food and Drug Administration (FDA) reviews. "They're acting as though there's no federal policy around stem cells," says bio-ethicist Leigh Turner of the University of Minnesota, Twin Cities.